Recent insider selling at Fortive suggests shares may be overpriced. Despite profitability and growth, the history of share sales is concerning. High insider ownership aligns management with shareholders, but lack of insider buying is worrisome.
Fortive's high P/E ratio is justified by its superior earnings outlook. Shareholders' confidence in future earnings and the company's strong growth outlook make a significant share price drop unlikely.
CEO James A. Lico is confident in the company's 2024 outlook, citing a history of mid-single-digit core growth and mid-teens compounded earnings and free cash flow annually since 2019. He also emphasized the company's successful strategy and its impact over time.
Fortive's CEO views the acquisition as a significant stepping-stone for their Precision Technologies segment, hopeful of the synergies it'll bring to customer solutions and financial results. Foresees EA's addition to assist in the growing multi-industry market.
Fortive's projected growth could be factored into its current share price, possibly making it overvalued. Despite promising future growth, current pricing may not provide the best entry point for investors. Analysts suggest limited upside due to pricing alignment, with further exploration advised should prices decrease in light of growth prospects.
Gainers -$Luna Innovations(LUNA.US)$+8.55% (acquires LIOS Sensing from NKT A/S' NKT Photonics for 20 million in cash; divested Luna Labs for $21 mln) -$Clene(CLNN.US)$+3.5% (Presents Updated Clinical Data from Phase 2 RESCUE-ALS and REPAIR trials and Preclinical ALS data at 2022 MDA Clinical & Scientific Conference) -$阿斯利康(AZN.US)$+2.3% ( AstraZeneca and$默沙東(MRK.US)$'s Lynparza (olaparib) has been approved in the ...
$Fortive(FTV.US)$Fortive (FTV) with two target raises. Stock currently around $76 Morgan Stanley from $78 to $82 at Equal Weight Credit Suisse from $84 to $87 at Outperform $慧與科技(HPE.US)$Hewlett Packard (HPE) target raised by Raymond James from $19 to $20 at Outperform. Stock currently around $14.50 $好時(HSY.US)$The Hershey (HSY) with a host of target raises. Average price target $200 at Overweight. Stock currently around $175
Fortive股票討論區
專欄US Top Gap Ups and Downs on 4/12: MDB, NET, JD, AAL and More
Gap Ups
1. $National Instruments(NATI.US)$ - up 8.7%
2. $MongoDB(MDB.US)$ - up 3.1%
3. $查特工業(GTLS.US)$ - up 2.9%
4. $Confluent(CFLT.US)$ - up 1.9%
5. $如瑞迪博士(RDY.US)$ - up 1.6%
6. $Cosan(CSAN.US)$ - up 1.6%
7. $Fortive(FTV.US)$ - up 1.5%
8. $Cloudflare(NET.US)$ - up 1.4%...
專欄Top upgrades and downgrades on 3/17
• $艾斯本科技(AZPN.US)$ : Loop Capital Upgrades to Buy from Hold - PT $175
• $CSX運輸(CSX.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $39 (from $37)
• $藝康集團(ECL.US)$ : Edward Jones Upgrades to Buy from Hold
• $Fortive(FTV.US)$ : Argus Upgrades to Buy from Hold - PT $68
• $Health Catalyst(HCAT.US)$ : Jefferies Upgrades To Buy From Hold - PT $28 (From $31)
• $亨廷頓英格爾斯工業(HII.US)$ : Vertical Research Upgra...
專欄Today's pre-market stock movers: AZN, NVS, NKLA, CVX and more
- $Luna Innovations(LUNA.US)$ +8.55% (acquires LIOS Sensing from NKT A/S' NKT Photonics for 20 million in cash; divested Luna Labs for $21 mln)
- $Clene(CLNN.US)$ +3.5% (Presents Updated Clinical Data from Phase 2 RESCUE-ALS and REPAIR trials and Preclinical ALS data at 2022 MDA Clinical & Scientific Conference)
- $阿斯利康(AZN.US)$ +2.3% ( AstraZeneca and $默沙東(MRK.US)$ 's Lynparza (olaparib) has been approved in the ...
專欄Top upgrades and downgrades on 3/14
• $BRP Group(BRP.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $31
• $Centennial Resource Development(CDEV.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $12 (from $8)
• $易諾華(ENVA.US)$ : Janney Upgrades to Buy from Neutral - PT $49
• $Fortive(FTV.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $75
• $Helios Technologies(HLIO.US)$ : KeyBanc Upgrades to Overweight from Sector Weight - PT $90
• $赫爾默里奇和佩恩材料(HP.US)$ : Seaport...
Morgan Stanley from $78 to $82 at Equal Weight
Credit Suisse from $84 to $87 at Outperform
$慧與科技(HPE.US)$ Hewlett Packard (HPE) target raised by Raymond James from $19 to $20 at Outperform. Stock currently around $14.50
$好時(HSY.US)$ The Hershey (HSY) with a host of target raises. Average price target $200 at Overweight. Stock currently around $175
暫無評論